COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 3004: Articles 30031-30040  | Next

Estimating the ascertainment rate of SARS-CoV-2 infection in Wuhan, China: implications for management of the global outbreak
Lytras, T., Panagiotakopoulos, G., Tsiodras, S.
10.1101/2020.03.24.20042218 — Posted: 2020-03-26
Modes of contact and risk of transmission in COVID-19 among close contacts
Luo, L., Liu, D., Liao, X.-l., Wu, X.-b., Jing, Q.-l., Zheng, J.-z., Liu, F.-h., Yang, S.-g., Bi, B., Li, Z.-h., Liu, J.-p., Song, W.-q., Zhu, W., Wang, Z.-h., Zhang, X.-r., Chen, P.-l., Liu, H.-m., Cheng, X., Cai, M.-c., Huang, Q.-m., Yang, P., Yang, X.-f., Huang, Z.-g., Tang, J.-l., Ma, Y., Mao, C.
10.1101/2020.03.24.20042606 — Posted: 2020-03-26 Discussion: Onsite
Viral Kinetics and Antibody Responses in Patients with COVID-19
Tan, W., Lu, Y., Zhang, J., Wang, J., Dan, Y., Tan, Z., He, X., Qian, C., Sun, Q., Hu, Q., Liu, H., Ye, S., Xiang, X., Zhou, Y., Zhang, W., Guo, Y., Wang, X.-H., He, W., Wan, X., Sun, F., Wei, Q., Chen, C., Pan, G., Xia, J., Mao, Q., Chen, Y., Deng, G.
10.1101/2020.03.24.20042382 — Posted: 2020-03-26 Discussion: Onsite | Offsite
COVID-19 clinical characteristics, and sex-specific risk of mortality: Systematic Review and Meta-analysis
Nasiri, M. J., Haddadi, S., Tahvildari, A., Farsi, Y., Arbabi, M., Hasanzadeh, S., Jamshidi, P., Murthi, M., Mirsaeidi, M.
10.1101/2020.03.24.20042903 — Posted: 2020-03-26
Human leukocyte antigen susceptibility map for SARS-CoV-2
Nguyen, A., David, J. K., Maden, S. K., Wood, M. A., Weeder, B. R., Nellore, A., Thompson, R. F.
10.1101/2020.03.22.20040600 — Posted: 2020-03-26 Discussion: Onsite
A Multicentre Study of 2019 Novel Coronavirus Disease Outcomes of Cancer Patients in Wuhan, China
Zhang, H.-Y., Wang, L.-W., Chen, Y.-Y., Shen, X.-K., Wang, Q., Yan, Y.-Q., Yu, Y., Wu, Q., Wang, X., Zhong, Y.-H., Chua Lee Kiang, M., Xie, C.-H.
10.1101/2020.03.21.20037127 — Posted: 2020-03-26
Acute kidney injury at early stage as a negative prognostic indicator of patients with COVID-19: a hospital-based retrospective analysis
Xu, S., Fu, L., Fei, J., Xiang, H.-X., Xiang, Y., Tan, Z.-X., Li, M.-D., Liu, F.-F., Li, Y., Han, M.-F., Li, X.-Y., Yu, D.-X., Zhao, H., Xu, D.-X.
10.1101/2020.03.24.20042408 — Posted: 2020-03-26
Comorbid Diabetes Mellitus was Associated with Poorer Prognosis in Patients with COVID-19: A Retrospective Cohort Study
Zhang, Y., Cui, Y., Shen, M., Zhang, J., Liu, B., Dai, M., Chen, L., Han, D., Fan, Y., Zeng, Y., Li, W., Lin, F., Li, S., Chen, X., Pan, P.
10.1101/2020.03.24.20042358 — Posted: 2020-03-26
Early chest computed tomography to diagnose COVID-19 from suspected patients: A multicenter retrospective study
Miao, C., Jin, M., Miao, L., Yang, X., Huang, P., Xiong, H., Huang, P., Zhao, Q., Du, J., Hong, J.
10.1101/2020.03.24.20042432 — Posted: 2020-03-26
Coast-to-coast spread of SARS-CoV-2 in the United States revealed by genomic epidemiology
Fauver, J. R., Petrone, M. E., Hodcroft, E. B., Shioda, K., Ehrlich, H. Y., Watts, A. G., Vogels, C. B. F., Brito, A. F., Alpert, T., Muyombwe, A., Razeq, J., Downing, R., Cheemarla, N. R., Wyllie, A. L., Kalinich, C. C., Ott, I., Quick, J., Loman, N. J., Neugebauer, K. M., Greninger, A. L., Jerome, K. R., Roychoundhury, P., Xie, H., Shrestha, L., Huang, M.-L., Pitzer, V. E., Iwasaki, A., Omer, S. B., Khan, K., Bogoch, I., Martinello, R. A., Foxman, E. F., Landry, M.-L., Neher, R. A., Ko, A. I., Grubaugh, N. D.
10.1101/2020.03.25.20043828 — Posted: 2020-03-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).